The team is experienced with projects ranging from Phase 2 to Phase 4 clinical trials, pharmacokinetic (PK) studies, and PK sampling. The team also facilitates opportunities to conduct basic science and translational research.
| Pharmaceutical Industry-sponsored Multicentric Trials | Investigator-initiated Trials | |
|---|---|---|
| Assist investigators in developing scientifically-vigorous study protocols/proposals | x | |
| Development of Confidential Disclosure Agreements | x | |
| Development of site feasibility questionnaires | x | |
| Budget negotiation/contract development/management | x | x |
| Submission to regulatory bodies | x (OSPARS & IRB) | x (IRB and clinicaltrials.gov) |
| Site selection & initiation visits | x | |
| Facilitate recruitment and enrollment of study patients | x | x |
| Data collection & data entry | x | |
| Monitoring visits | x | |
| Study close out | x | |
| Generate reports, presentations, and manuscripts | x | x |